What is Shenzhen Kangtai Biological Products Co., Ltd.'s (300601.SZ) StockRank?

MoatMap's StockRank for Shenzhen Kangtai Biological Products Co., Ltd. (300601.SZ) is 51/100, with a Hold signal. This is a composite score combining Quality (55), Value (37), and Momentum (48) factor ranks across MoatMap's 19,000+ stock universe.

Does Shenzhen Kangtai Biological Products Co., Ltd. have an economic moat?

Shenzhen Kangtai Biological Products Co., Ltd. (300601.SZ) has a Quality factor score of 55/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Shenzhen Kangtai Biological Products Co., Ltd. a buy, hold, or sell?

MoatMap's current signal for Shenzhen Kangtai Biological Products Co., Ltd. (300601.SZ) is Hold, based on a StockRank of 51/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Shenzhen Kangtai Biological Products Co., Ltd. in?

Shenzhen Kangtai Biological Products Co., Ltd. (300601.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

300601.SZ

HOLDREMOVE

Shenzhen Kangtai Biological Products Co., Ltd. · Healthcare · China · $2.1B · Avg Vol: $26M/d

StockRank

P/E (TTM)

164.9x

ROE

0.8%

D/E

0.2x

Dividend %

0.3%

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Shenzhen Kangtai is a domestic vaccine manufacturer. It faces high regulatory hurdles and intense domestic competition, with no alignment to our CDMO pricing power theme.

COMPANY DESCRIPTION

Shenzhen Kangtai Biological Products Co., Ltd. is a leading Chinese biopharmaceutical company specializing in the research, development, and manufacture of human vaccines. The company's competitive moat is anchored by its dominant market share in China's hepatitis B vaccine market and a highly diversified product pipeline including combination vaccines. It operates as a critical public health partner, benefiting from high regulatory barriers and national immunization programs.

FINANCIAL SUMMARY

Year	2022	2023	2024	2025	CAGR
Revenue	467M	514M	392M	395M	-5.4%
EPS	-0.02	0.11	0.03	0.01	-72.1%
Shares	1.1B	1.1B	1.1B	1.1B	-0.3%
Debt	338M	364M	299M	279M	-6.2%
Equity	1.3B	1.4B	1.4B	1.4B	2.3%
Op CF	81M	153M	89M	94M	5.2%
Inv CF	-385M	-65M	-82M	-72M	—
Fin CF	-69M	-62M	-118M	-51M	—

PRICE (1M)-18.3%

SMA 50SMA 200

$1.71

RSI (14)

28.2

52W High

$3.11

From 52W High

0.6%

SCORE BREAKDOWN

Quality

ROIC

1.4%47.1

ROE

0.8%46.5

GP/Assets

13.1%31.7

Op. Margin

6.7%59.0

FCF/Assets

13.4%92.0

Piotroski

—83.5

Int. Cover

1.4x43.2

D/E Ratio

0.20x52.1

Current Ratio

2.87x51.2

Value

P/E (TTM)

164.9x5.7

EV/EBITDA

30.0x11.8

P/FCF

51.0x89.1

P/B

1.3x70.6

P/S

4.8x42.4

Div Yield

0.3%7.5

Momentum

52W High %

55%30.6

RS 6M

-33%37.9

SMA 50/200

0.87x25.7

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—94.7

Q Growth

49%76.1

FUNDAMENTALS

Market Cap

$2.1B

P/E (Forward)

32.1x

Gross Margin

69.2%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 300601.SZ are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
300601.SZ	Shenzhen Kangtai Biological Products Co., Ltd.(you)	$2.1B	51	HOLD
688131.SS	Shanghai Haoyuan Chemexpress Co., Ltd.	$2.3B	50	HOLD
603538.SS	Ningbo Menovo Pharmaceutical Co., Ltd.	$1.6B	51	HOLD
300199.SZ	Hybio Pharmaceutical Co., Ltd.	$3.0B	48	HOLD
002020.SZ	Zhejiang Jingxin Pharmaceutical Co., Ltd.	$1.7B	57	HOLD
600789.SS	Shandong Lukang Pharmaceutical Co.,Ltd.	$1.2B	48	HOLD
002675.SZ	Yantai Dongcheng Pharmaceutical Group Co.,Ltd.	$1.6B	43	HOLD
300558.SZ	Betta Pharmaceuticals Co., Ltd.	$3.3B	46	HOLD
688505.SS	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.	$1.1B	52	HOLD
000534.SZ	Wedge Industrial Co.,Ltd.	$2.5B	39	HOLD

Peer medians: ROE 4.8% · P/E 27.6x · Gross margin 53.0%

Shenzhen Kangtai Biological Products Co., Ltd. (300601.SZ) — Stock Score Summary

Shenzhen Kangtai Biological Products Co., Ltd. (300601.SZ) has a MoatMap StockRank of 51/100 based on Quality (55/100), Value (37/100), and Momentum (48/100) factor scores. The current signal is HOLD. Shenzhen Kangtai is a domestic vaccine manufacturer. It faces high regulatory hurdles and intense domestic competition, with no alignment to our CDMO pricing power theme.

Key Financial Metrics

Price	$1.71
Market Cap	$2.1B
P/E (TTM)	164.86
P/E (Forward)	32.06
Price/Book	1.33
Return on Equity	0.8%
Return on Invested Capital	1.4%
Debt/Equity	19.94
Gross Margin	69.2%
Operating Margin	6.7%
Revenue Growth	-2.2%
Dividend Yield	0.3%
Free Cash Flow	$41M

Shenzhen Kangtai Biological Products Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Shenzhen Kangtai Biological Products Co., Ltd.’s (300601.SZ) StockRank?: MoatMap’s StockRank for Shenzhen Kangtai Biological Products Co., Ltd. (300601.SZ) is 51/100, with a Hold signal. It is a composite of Quality (55), Value (37), and Momentum (48) factor ranks across MoatMap’s 19,000+ stock universe.
Does Shenzhen Kangtai Biological Products Co., Ltd. have an economic moat?: Shenzhen Kangtai Biological Products Co., Ltd. (300601.SZ) has a Quality factor score of 55/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Shenzhen Kangtai Biological Products Co., Ltd. a buy, hold, or sell?: MoatMap’s current signal for Shenzhen Kangtai Biological Products Co., Ltd. (300601.SZ) is Hold, based on a StockRank of 51/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Shenzhen Kangtai Biological Products Co., Ltd. in?: Shenzhen Kangtai Biological Products Co., Ltd. (300601.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).